SOMERSET, N.J., Feb. 13, 2026 /PRNewswire/ -- In recognition of National Cancer Prevention Month, ProCure Proton Therapy Center is urging men to prioritize prostate-specific antigen (PSA) ...

Terrance Freeman shares his experience at the UF Health Proton Therapy Institute in this week’s Good News feature.

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...

CURE highlights prostate cancer advancements from Day One of the 2026 ASCO Genitourinary Cancers Symposium.

Use of relugolix among prostate cancer patients is associated with QoL, high treatment adherence rates, and low rates of ...

Dr Fred Saad of the University of Montreal discusses the future direction of alpha emitter agents in the treatment of prostate cancer, emphasizing the logical progression of resea ...

MARCAP investigators conducted the first individual patient data meta-analysis of randomized trials (POSEIDON) evaluating the use and duration hormone therapy with postoperative radiation therapy in ...

Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients ...

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...